• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
REM
Click for more information
0.00% 2.8¢

REMSENSE TECHNOLOGIES LIMITED

Market Cap $4.644M  ! watchlist Created with Sketch. Add to my watchlist
Industrials Conglomerates

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
REM
Ann: Service contract award 		19/09/24 16 2.9K
19/09/24 Last post  BrIcKyBUM Comments Created with Sketch.  16  Views Created with Sketch.  2.9K 
REM
Ann: Change of Director's Interest Notice 		13/09/24 0 181
13/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  181 
REM
Ann: S708A statement 		13/09/24 0 120
13/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  120 
REM
Ann: Application for quotation of securities - REM 		13/09/24 0 94
13/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  94 
REM
Ann: Conversion of performance shares 		13/09/24 0 148
13/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  148 
REM
Ann: Notification regarding unquoted securities - REM 		13/09/24 0 124
13/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  124 
REM
Ann: Trading Halt 		12/09/24 6 994
12/09/24 Last post  karakulahian Comments Created with Sketch.  6  Views Created with Sketch.  994 
REM
Ann: Pause in Trading 		12/09/24 0 136
12/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  136 

See All Discussions arrow Created with Sketch.

Timeline

Change of Director's Interest Notice
13 Sep 13:08
 
S708A statement
13 Sep 13:07
 
Application for quotation of securities - REM
13 Sep 12:50
 
Conversion of performance shares
13 Sep 11:17
 
Notification regarding unquoted securities - REM
13 Sep 11:12
 
Service contract award
12 Sep 15:19
 
View More arrow Created with Sketch.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
(20min delay)
Last
2.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.644M
Open High Low Value Volume
2.8¢ 2.8¢ 2.8¢ $490 17.50K

Buyers (Bids)

No. Vol. Price($)
2 8519 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 17210 1
View Market Depth
Last trade - 12.57pm 20/09/2024 (20 minute delay) ?
REM (ASX) Chart

Top Stories

Tennant Minerals clocks high-grade gold, copper hits at Bluebird in the NT

Tennant Minerals has unveiled the results of its latest drill campaign at its Bluebird project, posting "high-grade" copper and gold hits.
Drilling shows continuous Cu mineralisation at Whundo for Greentech Greentech Metals Ltd has rolled out an extensive drilling program at the Whundo copper-zinc project 40 kilometres from Karratha
Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear Well, it finally happened – the US Fed cut interest rates this week, and we got a double dose: a whole -50bps knocked off.
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Harvey Norman hit with a second class action – and shareholders, once again, don't care Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.